Remdesivir can cause infusion reactions, diarrhea, anemia, hyperglycemia, and elevated alanine aminotransferase (ALT)/serum glutamate pyruvate transaminase (SGPT) and aspartate aminotransferase (AST) levels on long-term treatment. Here, GPT is linked to anemia (phenotype).